Company Filing History:
Years Active: 2009
Title: Paul H Wiedenau: Innovator in Antiparasitic Terpene Alkaloids
Introduction
Paul H Wiedenau is a notable inventor based in Deal, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antiparasitic agents. His work focuses on the innovative use of terpene alkaloids, which are compounds known for their medicinal properties.
Latest Patents
Wiedenau holds 1 patent for his invention titled "Antiparasitic Terpene Alkaloids." This patent relates to novel terpene alkaloids and their application as effective antiparasitic agents. The invention also encompasses an antiparasitic agent that includes a specific terpene alkaloid compound as an active ingredient in its formulation. More specifically, it details derivatives of the terpene alkaloid (1S,2R,4aS,5R,8R,8aR)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethenyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2S,3aR,9bR)-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate. Additionally, pharmaceutical compositions that incorporate these compounds are also disclosed in the patent.
Career Highlights
Wiedenau is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the advancement of medical science through innovative research and development.
Collaborations
Throughout his career, Wiedenau has collaborated with notable colleagues, including Nathan Anthony Chubb and Douglas James Critcher. These collaborations have fostered a productive environment for innovation and the development of new pharmaceutical solutions.
Conclusion
Paul H Wiedenau's contributions to the field of antiparasitic agents through his innovative work with terpene alkaloids highlight his role as a significant inventor in the pharmaceutical industry. His patent and collaborations reflect a commitment to advancing medical science and improving health